IQVIA is trading 4.1% up at $259.51 after healthcare stocks rallied broadly on improving earnings expectations, attractive valuations, and investor rotation from technology into defensive growth.
- XLV was up 3.23% during regular trading.
- Healthcare earnings forecasts and increased M&A activity supported the sector move.
- No new IQVIA-specific announcement or catalyst was identified for August 20, 2026.